Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin vs Active Control in Invasive Aspergillosis
NCT00376337Phase 2Terminated
- Sponsor
- Astellas Pharma
- Start
- Jun 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of micafungin in invasive aspergillosis (IA), sponsored by Astellas Pharma. Started Jun 2006; status: terminated.
02
Drugs
micafungin
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT00376337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376337.